Diuresis during 18F-flotufolastat (rhPSMA-7.3) PET/CT improves recurrence detection after prostatectomy : a prospective Phase II trial

Files

Lawal_Diuresis_2025.pdf (505.1 KB)

Lawal_DiuresisSupplTabs_2025.pdf (75.22 KB)

Date

Authors

Lawal, Ismaheel Opeyemi

Jani, Ashesh B.

Dhere, Vishal R.

Patel, Sagar A.

Bilen, Mehmet A.

Patel, Pretesh R.

Sebastian, Nikhil T.

Switchenko, Jeffrey M.

Publisher

Society of Nuclear Medicine and Molecular Imaging

Abstract

Please read abstract in the article.

Keywords

Prostate cancer (PCa), Furosemide, rhPSMA-7.3, 18F-flotufolastat, Prostate bed region, Biochemical recurrence

Sustainable Development Goals

SDG-03: Good health and well-being

Citation

Lawal, I.O., Mushtaq, A., Jani, A.B. et al. 2025, 'Diuresis during 18F-flotufolastat (rhPSMA-7.3) PET/CT improves recurrence detection after prostatectomy : a prospective Phase II trial', Journal of Nuclear Medicine, vol. 66, no. 2, pp. 230-237, doi : 10.2967/jnumed.124.268574.

URI

http://hdl.handle.net/2263/104697

Collections

Postprints (Articles)
Research Articles (University of Pretoria)